Patents by Inventor George V. DeLucca

George V. DeLucca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
    Patent number: 6441001
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: August 27, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Paul S. Watson, Soo S. Ko, George V. Delucca, Joseph B. Santella, III, Dean A. Wacker, John V. Duncia
  • Heterocycyclic piperidines as modulators of chemokine receptor activity
    Patent number: 6331545
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: December 18, 2001
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6331541
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: December 18, 2001
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Daniel S. Gardner
  • Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
    Patent number: 6313110
    Abstract: The present invention relates to a compound of Formula (I): or pharmaceutically acceptable salt forms or prodrugs thereof, which are useful as inhibitors of HIV protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: November 6, 2001
    Assignee: Dupont Pharmaceuticals Company
    Inventor: George V. DeLucca
  • High strength chitosan fibers and fabrics thereof
    Patent number: 4861527
    Abstract: High strength chitosan fibers from chitin and chitosan derivatives and the process for making these fibers are disclosed.
    Type: Grant
    Filed: February 8, 1988
    Date of Patent: August 29, 1989
    Inventors: George V. DeLucca, Lorenzo F. Pelosi, John P. O'Brien